Dec 02, 2020 7:00am EST RenovoRx Continues with Strong Momentum and Reaches Milestone of 100th Patient Enrolled in its Phase III TIGeR-PaC Clinical Trial
Sep 15, 2020 6:00am EDT RenovoRx Named 2020 Drug Delivery Technology Winner in the Fierce Innovation Awards for Life Sciences
Jun 02, 2020 7:00am EDT RenovoRx Announces Orphan Drug Designation Granted for Treating Bile Duct Cancer
May 23, 2018 8:00am EDT RenovoRx Announces $10 Million Financing for Innovative Treatment for Advanced Pancreatic Cancer
Apr 19, 2017 1:37pm EDT Researchers Report Survival Benefits with Use of RenovoCath™ in Patients with Locally Advanced Pancreatic Tumors
